Cargando…
Predicting the efficacy of cancer vaccines by evaluating T-cell responses
In a preclinical experimental model of human papilloma virus (HPV)-induced cervical carcinoma, we have shown that the efficacy of cancer vaccines can be predicted by the evaluation of vaccine-induced T-cell responses in healthy subjects. We argue that such knowledge can be used to screen candidates...
Autores principales: | van Duikeren, Suzanne, Arens, Ramon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583929/ https://www.ncbi.nlm.nih.gov/pubmed/23482345 http://dx.doi.org/10.4161/onci.22616 |
Ejemplares similares
-
Local immunomodulation for cancer therapy: Providing treatment where needed
por: Fransen, Marieke F, et al.
Publicado: (2013) -
Exploiting invariant NKT cells to promote T-cell responses to cancer vaccines
por: Hunn, Martin K., et al.
Publicado: (2013) -
Single-dose cyclophosphamide synergizes with immune responses to the renal cell cancer vaccine IMA901
por: Walter, Steffen, et al.
Publicado: (2013) -
Sound efficacy of prophylactic HPV vaccination: Basics and implications
por: Lehtinen, Matti, et al.
Publicado: (2012) -
Targeting MDSCs enhance therapeutic vaccination responses against lung cancer
por: Srivastava, Minu K., et al.
Publicado: (2012)